Meclizine HCL 25 mg Tablet, Chewable, 30-count
by Aphena Pharma Solutions - Tennessee, LLC · 30 TABLET, CHEWABLE in 1 BOTTLE (71610-528-30)
NDC 71610-0528-30
🏷️ FDA NDC (as labeled)
71610-528-30
billing pads the product segment with a zero
This package
Contains30-count
Pack sizes2 compare ↓
Also comes in:
90 tablets 71610-0528-60
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
71610-528-30
Product NDC
71610-528
11-digit billing NDC
71610052830
NCPDP billing unit
EA — each (per item)
RxCUI
995632
UNII
HDP7W44CIO
Application #
M012
SPL Set ID
02d1af4d-d97d-4019-a5bf-3ec391238676
Established class (EPC)
Antiemetic
Physiologic effect
Emesis Suppression
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2015-05-01
Route
ORAL
Dosage form
TABLET, CHEWABLE
Substance
MECLIZINE HYDROCHLORIDE
GPI-14
50200050000510
GPI class
Meclizine HCl
GCN Seq No
004736
GCN
18312
HICL code
001975
Ingredient (HICL)
Meclizine Hcl
HIC1 code
H
Therapeutic class — broad (HIC1)
Nervous System (Except Autonomic)
HIC2 code
H6
Therapeutic class — intermediate (HIC2)
Drugs Acting Principally On The Midbrain
HIC3 code
H6J
Therapeutic class — specific (HIC3)
Antiemetic/Antivertigo Agents
AHFS code
04:04.16.00
AHFS class
Piperazine Derivatives
FDB label name
MECLIZINE 25 MG TABLET CHEW
FDB brand name
Meclizine Hcl
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 71610-528-30 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 71610-0528-30. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Antiemetic class.
Pharmacologic class
Antiemetic
Drug family (ATC)
Piperazine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerAphena Pharma Solutions - Tennessee, LLC
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code71610
First marketedMay 2015
Product typeHuman Otc Drug
Portfolio800 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name MECLIZINE 25 MG TABLET CHEW Ingredient Meclizine Hcl
📖 What it is MedlinePlus · NLM
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
- For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
- Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
- This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Meclizine HCl 25mg Chewable Tablets?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
red
ShapeRound
ImprintAP;115
Size8 mm
ScoringScored — splits in 2
FlavorRaspberry
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII Z0H242BBR1
Aspartame is an artificial sweetener made from amino acids. It's added to medicines to improve taste, making bitter or unpleasant-tasting drugs easier to take.
-
UNII M28OL1HH48
Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
-
UNII IY9XDZ35W2
Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
-
UNII WZB9127XOA
A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII 4N14V5R27W
A natural flavoring derived from raspberry fruit that gives medicines a pleasant taste. It helps mask bitter or unpleasant flavors to make medications easier to swallow.
-
UNII C151H8M554
A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
8 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesAspartame, compressible sugar, croscarmellose sodium, dextrose, FD&C red 40 (al-lake), magnesium stearate, microcrystalline cellulose, raspberry flavor
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
90 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Meclizine Hydrochloride 25 mg 00536-1299-01 | Rugby | 100 tablets | $0.033 | — | Availability likely | — |
| Meclizine HCl 25 mg 16571-0824-01 | Rising | 100 tablets | $0.033 | — | Availability likely | — |
| Motion Sickness Relief 25 mg 46122-0774-51 | Amerisource | 8 tablets | $0.033 | — | Availability likely | — |
| Motion-Time Chewable 25 mg/251 49483-0333-01 | Time-Cap | 100 tablets | $0.033 | — | Availability likely | — |
| Meclizine HCl 25 mg 68001-0529-00 | BluePoint | 100 tablets | $0.033 | — | Availability likely | — |
| Motion Sickness 25 mg 70677-1290-01 | Strategic | 100 tablets | $0.033 | — | Availability likely | — |
| Travel ease 25 mg 83324-0027-16 | Chain | 8 tablets | $0.033 | — | Availability likely | — |
| Motion Sickness Relief 25 mg 00363-4040-21 | Walgreen | 8 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 00363-5172-07 | Walgreen | 12 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 11822-4040-01 | Rite | 8 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 16103-0387-08 | Pharbest | 100 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 16571-0663-01 | Rising | 100 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 17714-0115-01 | Advance | 100 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 37835-0202-01 | Bi-Mart | 100 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 43063-0804-01 | PD-Rx | 100 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-5496-00 | A-S | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-5952-00 | A-S | 30 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 51013-0322-54 | PuraCap | 2 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 51316-0404-21 | CVS | 8 tablets | — | — | FDA listed | — |
| Motion Sickness 25 mg 51316-0441-21 | CVS | 8 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 54738-0025-01 | Richmond | 100 tablets | — | — | FDA listed | — |
| Dramamine 25 mg 63029-0906-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Dramamine 25 mg 63029-0913-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Dramamine 25 mg 63029-0914-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Bonine 25 mg 65197-0275-02 | WellSpring | 2 tablets | — | — | FDA listed | — |
| Bonine 25 mg 65197-0296-08 | WellSpring | 8 tablets | — | — | FDA listed | — |
| Bonine 25 mg 65197-0297-08 | WellSpring | 8 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 68071-2574-02 | NuCare | 20 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 68788-7982-01 | Preferred | 10 tablets | — | — | FDA listed | — |
| Meclizine HCl 25 mg 68788-8529-01 | Preferred | 10 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 69618-0028-01 | Reliable | 100 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 69842-0395-54 | CVS | 2 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71205-0606-30 | Proficient | 30 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 71335-1215-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71335-1607-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 71335-2177-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine HCl 25 mg 71335-9751-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mgthis 71610-0528-30 | Aphena | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 71610-0836-30 | Aphena | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 72789-0250-12 | PD-Rx | 12 tablets | — | — | FDA listed | — |
| Meclizine 25 mg 80513-0421-02 | Advanced | 200 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2015
On the market since
May 2015
📍
2026
Currently FDA-listed
11 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Meclizine HCl — the program that covers self-administered drugs. 8 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Meclizine HCl. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$6.73M
Claims incl. refills
748.9K
Beneficiaries
532.6K
Spend / beneficiary
$12.64
Spend / claim
$8.99
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Meclizine HCL (this brand).
Top reported reactions
Reporter sex
Male · 25%
Female · 75%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 71610-0528-30 You're viewing this | 30 TABLET, CHEWABLE in 1 BOTTLE (71610-528-30) | 2021-03-04 | Active |
| 71610-0528-60 | 90 TABLET, CHEWABLE in 1 BOTTLE (71610-528-60) | 2021-03-04 | Active |
You're viewing the smallest of 2 pack sizes for this product.
Pack size FAQ
What quantity is in NDC 71610-0528-30?
NDC 71610-0528-30 is a 30-count package — 30 tablet, chewable in 1 bottle.
What is the difference between NDC 71610-0528-30 and NDC 71610-0528-60?
Both are Meclizine HCL 25 mg Tablet, Chewable — the drug itself is identical. NDC 71610-0528-30 is the 30-count package, while NDC 71610-0528-60 is the 90 tablets package.
What NDC number is used to bill for this package of Meclizine HCL 25 mg Tablet, Chewable?
Bill NDC 71610-0528-30 — the 11-digit billing format is 71610052830. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 71610-528-30, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 71610-0528-30, written without dashes as 71610052830. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 71610-0528-30, the first segment (71610) is the labeler code FDA assigned to Aphena Pharma Solutions - Tennessee, LLC; the middle segment (0528) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (30) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Aphena Pharma Solutions - Tennessee, LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 90 tablets (71610-0528-60). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Aphena Pharma Solutions - Tennessee, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses For the prevention and treatment of nausea, vomiting or dizziness associated with motion sickness. For other uses consult your doctor
⏱️ Dosage and Administration ▾
Directions take dose one hour before travel starts tablets can be chewed or swallowed whole with water adults & children 12 years and over: take 1-2 tablets once daily children under 12 years: ask a doctor
⚠️ Warnings ▾
Warnings Ask a doctor before use if you have glaucoma a breathing problem such as emphysema or chronic bronchitis trouble urinating due to an elarged prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers When using this product you may get drowsy avoid alcoholic drinks alcohol, sedatives and tranquilizers may increse drowsiness be careful when driving a moor vehicle or operating machinery
🧪 Active Ingredient ▾
Active ingredient Meclizine Hydrochloride 25 mg
🧪 Inactive Ingredients ▾
Inactive ingredients Aspartame, compressible sugar, croscarmellose sodium, dextrose, FD&C red 40 (al-lake), magnesium stearate, microcrystalline cellulose, raspberry flavor
🎯 Purpose ▾
Purpose Antiemetic
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.